For the Inventor, By the Inventor

Enter assignee name

Parsippany, NJ, United States of America

Alteon Incorporated

USPTO Granted Patents = 55

Forward Citations = 463

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Dilip R Wagle (31 out of 34 patents)

Peter C Ulrich (26 out of 79 patents)

Anthony Cerami (25 out of 167 patents)

4. John J Egan (9 out of 15 patents)

5. San-Bao Hwang (9 out of 10 patents)

6. Henry W Founds (9 out of 10 patents)

7. Michael E Lankin (8 out of 23 patents)

8. Martin Gall (8 out of 9 patents)

9. Sara Vasan (7 out of 10 patents)

10. David H Shih (5 out of 5 patents)

11. Homayoun Sadeghi (5 out of 5 patents)

12. Edmond Joseph LaVoie (4 out of 63 patents)

13. Stanley Charles Bell (4 out of 55 patents)

14. Richard J Bucala (3 out of 57 patents)

15. Sheng Ding Fang (3 out of 5 patents)

Core Competencies:

Fibrotic Diseases

Advanced Glycosylation Endproducts

Monoclonal Antibodies

Thiazole Compounds

Oxazole Compounds

Imidazole Compounds

Glucose Lowering Compounds

Lipid Lowering Compounds

Glycosylation Inhibition

Pharmaceutical Compositions

Protein Aging

Hydrazones

55 patents: Sort by Forward Citations

1. 7166625 - Method for treating fibrotic diseases and other indications (2007-01-23),

2. 7144570 - Sunscreen compositions and methods of use thereof (2006-12-05),

3. RE39138 - Monoclonal antibody specific for advanced glycosylation endproducts in biological samples (2006-06-19),

4. 7026342 - Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds (2006-04-11),

5. 7022719 - Preventing and reversing the formation of advance glycosylation endproducts (2006-04-04),

6. 6960605 - Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging (2005-11-01),

7. 6806268 - Method for treating glaucoma V (2004-10-19),

8. 6790859 - Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds (2004-09-14),

9. 6770663 - Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds (2004-08-03),

10. 6713498 - Method for treating glaucoma VI (2004-03-30),

11. 6610716 - Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging (2003-08-26),

12. 6596745 - Method for treating fibrotic diseases with azolium chroman compounds (2003-07-22),

13. 6596744 - Method for treating fibrotic diseases or other indications IIC (2003-07-22),

14. 6509480 - Glucose and lipid lowering compounds (2003-01-21),

15. 6506902 - Synthesis of thiazolium compounds (2003-01-14),

Alteon Incorporated is a leading global provider of network traffic management solutions. With over 20 years of experience in the industry, we design and develop cutting-edge technologies that help businesses optimize the performance, availability, and security of their networks. Our comprehensive product portfolio includes load balancers, application delivery controllers, and network security solutions. Partnering with us enables businesses to ensure seamless application delivery, improve user experience, and enhance the overall efficiency of their network infrastructure.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

55 Patents

#13 in Parsippany, NJ

#265 in New Jersey

#6,244 in US

#12,575 in the World

Parsippany, NJ, United States of America

Alteon Incorporated

Forward Citations = 463

30 inventors:

Dilip R Wagle (31 out of 34 patents)

Peter C Ulrich (26 out of 79 patents)

Anthony Cerami (25 out of 167 patents)

4. John J Egan (9 out of 15 patents)

5. San-Bao Hwang (9 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…